JPWO2023120405A1 - - Google Patents
Info
- Publication number
- JPWO2023120405A1 JPWO2023120405A1 JP2023569389A JP2023569389A JPWO2023120405A1 JP WO2023120405 A1 JPWO2023120405 A1 JP WO2023120405A1 JP 2023569389 A JP2023569389 A JP 2023569389A JP 2023569389 A JP2023569389 A JP 2023569389A JP WO2023120405 A1 JPWO2023120405 A1 JP WO2023120405A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021209565 | 2021-12-23 | ||
PCT/JP2022/046359 WO2023120405A1 (en) | 2021-12-23 | 2022-12-16 | COMPOSITION FOR MINIMIZING PRODUCTION AND/OR ACCUMULATION OF AMYLOID β |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2023120405A1 true JPWO2023120405A1 (en) | 2023-06-29 |
Family
ID=86902612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2023569389A Pending JPWO2023120405A1 (en) | 2021-12-23 | 2022-12-16 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2023120405A1 (en) |
TW (1) | TW202342088A (en) |
WO (1) | WO2023120405A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024095906A1 (en) * | 2022-11-01 | 2024-05-10 | サントリーホールディングス株式会社 | Composition for preventing or inhibiting inflammation of neural cells |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011055247A1 (en) * | 2009-11-09 | 2011-05-12 | Jawaharlal Nehru Centre For Advanced Scientific Research | A synthetic cyclic dipeptide and a process thereof |
WO2013021353A1 (en) * | 2011-08-11 | 2013-02-14 | Bar-Ilan University | Surface modified proteinaceous spherical particles and uses thereof |
JP6669750B2 (en) * | 2015-07-16 | 2020-03-18 | サントリーホールディングス株式会社 | Composition for inhibiting serum carnosine degrading enzyme containing cyclic dipeptide |
JP6687619B2 (en) * | 2015-07-17 | 2020-04-22 | サントリーホールディングス株式会社 | Composition for antagonisting melanin-concentrating hormone receptor |
WO2017119481A1 (en) * | 2016-01-08 | 2017-07-13 | サントリーホールディングス株式会社 | Cyclic dipeptide-containing composition for preventing neurological diseases |
JP6598412B1 (en) * | 2019-06-04 | 2019-10-30 | ゼライス株式会社 | Food for improving cognitive function |
-
2022
- 2022-12-16 WO PCT/JP2022/046359 patent/WO2023120405A1/en active Application Filing
- 2022-12-16 JP JP2023569389A patent/JPWO2023120405A1/ja active Pending
- 2022-12-23 TW TW111149668A patent/TW202342088A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023120405A1 (en) | 2023-06-29 |
TW202342088A (en) | 2023-11-01 |